NO20084253L - Tetrahydroisokinolinderivater for a forbedre hukommelsesfunksjon - Google Patents

Tetrahydroisokinolinderivater for a forbedre hukommelsesfunksjon

Info

Publication number
NO20084253L
NO20084253L NO20084253A NO20084253A NO20084253L NO 20084253 L NO20084253 L NO 20084253L NO 20084253 A NO20084253 A NO 20084253A NO 20084253 A NO20084253 A NO 20084253A NO 20084253 L NO20084253 L NO 20084253L
Authority
NO
Norway
Prior art keywords
memory function
tetrahydroisoquinoline derivatives
improve memory
tetrahydroisoquinoline
derivatives
Prior art date
Application number
NO20084253A
Other languages
English (en)
Inventor
Francois Jenck
Original Assignee
Actelion Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actelion Pharmaceuticals Ltd filed Critical Actelion Pharmaceuticals Ltd
Publication of NO20084253L publication Critical patent/NO20084253L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Oppfinnelsen vedrører anvendelsen av tetrahydroisokinolinderivater for fremstilling av et medikament for å forbedre, opprettholde de og/eller gjenopprette alle stadier og/eller typer av kort-, mellomlang- og/eller langtidshukommelse.
NO20084253A 2006-03-15 2008-10-10 Tetrahydroisokinolinderivater for a forbedre hukommelsesfunksjon NO20084253L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IB2006050812 2006-03-15
PCT/IB2007/050868 WO2007105177A1 (en) 2006-03-15 2007-03-14 Tetrahydroisoquinoline derivatives to enhance memory function

Publications (1)

Publication Number Publication Date
NO20084253L true NO20084253L (no) 2008-10-10

Family

ID=38181192

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20084253A NO20084253L (no) 2006-03-15 2008-10-10 Tetrahydroisokinolinderivater for a forbedre hukommelsesfunksjon

Country Status (16)

Country Link
US (1) US20090082394A1 (no)
EP (1) EP1998774A1 (no)
JP (3) JP4582722B2 (no)
KR (1) KR101065239B1 (no)
CN (1) CN101400348A (no)
AU (1) AU2007226203A1 (no)
BR (1) BRPI0708913A2 (no)
CA (1) CA2644010A1 (no)
CR (1) CR10260A (no)
EA (1) EA015256B1 (no)
IL (1) IL194044A0 (no)
MA (1) MA30327B1 (no)
MX (1) MX2008011647A (no)
NO (1) NO20084253L (no)
UA (1) UA93903C2 (no)
WO (1) WO2007105177A1 (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1751111E (pt) 2004-03-01 2015-04-01 Actelion Pharmaceuticals Ltd Derivados de 1,2,3,4-tetrahidroisoquinolina substituída
US20090082394A1 (en) * 2006-03-15 2009-03-26 Actelion Pharmaceuticals, Ltd. Tetrahydroisoquinoline Derivatives to Enhance Memory Function
ATE496051T1 (de) * 2006-04-26 2011-02-15 Actelion Pharmaceuticals Ltd Pyrazolotetrahydropyridinderivate als orexinrezeptorantagonisten
ATE545647T1 (de) 2006-12-22 2012-03-15 Actelion Pharmaceuticals Ltd 5,6,7,8-tetrahydro-imidazoä1,5-aüpyrazinderivat
CN101646668A (zh) 2007-04-04 2010-02-10 弗·哈夫曼-拉罗切有限公司 作为食欲肽拮抗剂的杂环类
PE20091010A1 (es) 2007-10-10 2009-08-08 Actelion Pharmaceuticals Ltd Derivados de tetrahidroquinolina
EP2231155A4 (en) 2007-12-18 2011-09-14 Concert Pharmaceuticals Inc Tetrahydroisoquinoline DERIVATIVES
KR101579992B1 (ko) 2007-12-28 2015-12-23 액테리온 파마슈티칼 리미티드 삼치환된 3,4-디하이드로-1ｈ-이소퀴놀린 화합물, 상기 화합물의 제조 공정 및 상기 화합물의 용도
KR20110036069A (ko) 2008-06-25 2011-04-06 액테리온 파마슈티칼 리미티드 5,6,7,8-테트라히드로-이미다조[1,5-ａ]피라진 화합물
WO2010095106A1 (en) 2009-02-20 2010-08-26 Actelion Pharmaceuticals Ltd Solid forms of ( 2r) -2- { ( is ) -6, 7 -dimethoxy- 1- [2- (4-triflu0r0methyl-phenyl) -ethyl] -3, 4-dihydr0-1h -isoquinolin-2-yl} -n-methyl-2-phenyl-acetamide hydrochloride
TW201209037A (en) 2010-08-24 2012-03-01 Actelion Pharmaceuticals Ltd Proline sulfonamide derivatives as orexin receptor antagonists
WO2012039371A1 (ja) 2010-09-22 2012-03-29 エーザイ・アール・アンド・ディー・マネジメント株式会社 シクロプロパン化合物
CN103201261A (zh) 2010-11-10 2013-07-10 埃科特莱茵药品有限公司 用作为食欲素受体拮抗剂的内酰胺衍生物
WO2012085852A1 (en) 2010-12-22 2012-06-28 Actelion Pharmaceuticals Ltd 3,8-diaza-bicyclo[4.2.0]oct-8-yl amides
KR101873083B1 (ko) 2011-02-18 2018-06-29 이도르시아 파마슈티컬스 리미티드 오렉신 길항제로서 유용한 신규 피라졸 및 이미다졸 유도체
WO2012114252A1 (en) 2011-02-21 2012-08-30 Actelion Pharmaceuticals Ltd Novel indole and pyrrolopyridine amides
WO2013050938A1 (en) 2011-10-04 2013-04-11 Actelion Pharmaceuticals Ltd 3,7-diazabicyclo[3.3.1]nonane and 9-oxa-3,7-diazabicyclo[3.3.1]nonane derivatives
TWI565703B (zh) 2011-11-08 2017-01-11 艾克泰聯製藥有限公司 ２-（１，２，３-三唑-２-基）苯甲醯胺及３-（１，２，３-三唑-２-基）吡啶醯胺衍生物
KR101689093B1 (ko) 2012-06-04 2016-12-22 액테리온 파마슈티칼 리미티드 벤즈이미다졸-프롤린 유도체
BR112015007516A2 (pt) 2012-10-10 2017-07-04 Actelion Pharmaceuticals Ltd antagonistas do receptor de orexina que são derivados de [orto bi-(hetero-)aril]-[2-(meta bi-(hetero-)aril)- pirrolidin-1-il]-metanona
CA2902135A1 (en) 2013-03-12 2014-09-18 Actelion Pharmaceuticals Ltd Azetidine amide derivatives as orexin receptor antagonists
UA119151C2 (uk) 2013-12-03 2019-05-10 Ідорсія Фармасьютікалз Лтд КРИСТАЛІЧНА СОЛЬОВА ФОРМА (S)-(2-(6-ХЛОР-7-МЕТИЛ-1H-БЕНЗО[d]ІМІДАЗОЛ-2-ІЛ)-2-МЕТИЛПІРОЛІДИН-1-ІЛ)(5-МЕТОКСИ-2-(2H-1,2,3-ТРИАЗОЛ-2-ІЛ)ФЕНІЛ)МЕТАНОНУ ЯК АНТАГОНІСТ ОРЕКСИНОВОГО РЕЦЕПТОРА
HK1225731B (en) 2013-12-03 2017-09-15 Idorsia Pharmaceuticals Ltd Crystalline form of (s)-(2-(6-chloro-7-methyl-1h-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1 -yl)(5-methoxy-2-(2h-1,2,3-triazol-2-yl)phenyl)methanone and its use as orexin receptor antagonists
HRP20181710T1 (hr) 2013-12-04 2018-12-28 Idorsia Pharmaceuticals Ltd Uporaba derivata benzimidazol-prolina
MX376164B (es) 2014-10-23 2025-03-07 Eisai R&D Man Co Ltd Composiciones y metodos para tratar el insomnio.
WO2020007964A1 (en) 2018-07-05 2020-01-09 Idorsia Pharmaceuticals Ltd 2-(2-azabicyclo[3.1.0]hexan-1-yl)-1h-benzimidazole derivatives
WO2020007977A1 (en) 2018-07-06 2020-01-09 Idorsia Pharmaceuticals Ltd 7-trifluoromethyl-[1,4]diazepan derivatives
WO2020099511A1 (en) 2018-11-14 2020-05-22 Idorsia Pharmaceuticals Ltd Benzimidazole-2-methyl-morpholine derivatives
AR129309A1 (es) 2022-05-13 2024-08-07 Idorsia Pharmaceuticals Ltd Derivados de hidrazina-n-carboxamida cíclica sustituida con tiazoloaril-metilo

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2703050B1 (fr) * 1993-03-24 1995-04-28 Adir Nouveaux dérivés bicycliques azotés, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
GB9319732D0 (en) * 1993-09-24 1993-11-10 Ucb Sa Use of (s)-alpha-ethyl-2-oxo-l-pyrrolidineacetamide for the treatment of anxiety
JP3942207B2 (ja) * 1995-02-17 2007-07-11 武田薬品工業株式会社 うつ性症状改善剤
DE60108236T2 (de) * 2000-03-14 2005-12-22 Actelion Pharmaceuticals Ltd. 1,2,3,4-tetrahydroisochinolin-derivate
EP1288202A4 (en) * 2000-05-11 2003-07-02 Banyu Pharma Co Ltd N-acyltetrahydroisoquinoline derivatives
WO2002051232A2 (en) * 2000-12-27 2002-07-04 Actelion Pharmaceuticals Ltd. Novel benzazepines and related heterocyclic derivatives
ES2329354T3 (es) * 2002-04-26 2009-11-25 F. Hoffmann-La Roche Ag Derivados de isoquinolina.
MXPA05010137A (es) * 2003-03-26 2005-11-16 Actelion Pharmaceuticals Ltd Derivados de tetrahidroisoquinolil acetamida para usarse como antagonistas del receptor de orexina.
PT1751111E (pt) * 2004-03-01 2015-04-01 Actelion Pharmaceuticals Ltd Derivados de 1,2,3,4-tetrahidroisoquinolina substituída
FR2874011B1 (fr) 2004-08-03 2007-06-15 Sanofi Synthelabo Derives de sulfonamides, leur preparation et leur application en therapeutique
US20090082394A1 (en) * 2006-03-15 2009-03-26 Actelion Pharmaceuticals, Ltd. Tetrahydroisoquinoline Derivatives to Enhance Memory Function

Also Published As

Publication number Publication date
CR10260A (no) 2008-10-03
CA2644010A1 (en) 2007-09-20
KR101065239B1 (ko) 2011-09-16
JP2010248237A (ja) 2010-11-04
IL194044A0 (en) 2009-09-22
CN101400348A (zh) 2009-04-01
MA30327B1 (fr) 2009-04-01
JP2009530265A (ja) 2009-08-27
US20090082394A1 (en) 2009-03-26
WO2007105177A1 (en) 2007-09-20
JP4582722B2 (ja) 2010-11-17
EP1998774A1 (en) 2008-12-10
BRPI0708913A2 (pt) 2011-06-14
UA93903C2 (ru) 2011-03-25
EA015256B1 (ru) 2011-06-30
AU2007226203A1 (en) 2007-09-20
KR20080103597A (ko) 2008-11-27
JP2010270127A (ja) 2010-12-02
EA200870357A1 (ru) 2009-02-27
MX2008011647A (es) 2008-09-22

Similar Documents

Publication Publication Date Title
NO20084253L (no) Tetrahydroisokinolinderivater for a forbedre hukommelsesfunksjon
NO20082793L (no) Nye tiofenderivater
EA200801758A1 (ru) Лекарственные формы, устойчивые к самовольному изменению
TNSN08178A1 (en) Triazolopyridine derivatives as inhibitors of lipases and phospholipases
PT2049557E (pt) Derivados de 1-(d-glicopiranosil)-3-(4- ciclopropilfenilmetil)-4-halogeno-indol e a sua utiliza??o como inibidores de tgds
ATE447568T1 (de) Neue pyrinderivate
NO20090596L (no) Antivirale fosfinatforbindelser
WO2008070268A3 (en) Pharmaceutical compositions
WO2007106436A3 (en) Photoactive compounds and compositions and uses thereof
NO20082298L (no) Kaliumkanalinhibitorer
WO2009071689A3 (de) 5-halogen-substituierte oxindol-derivate und ihre verwendung zur behandlung von vasopressin-abhängigen erkrankungen
ATE506340T1 (de) 12-aryl-prostaglandin-analoga
BRPI0717369A2 (pt) Composto, medicamento, composição farmacêutica que o contém e uso do composto.
UA91848C2 (ru) Применение соединений диосметина в лечении и предотвращении тромботическим патологиям
AR054507A1 (es) Sistema transdermico de vareniclina
TW200633992A (en) Biaryloxymethylarenecarboxylic acids
NO20075140L (no) Fremgangsmater og preparater for modulering av vaskulaer integritet
CL2010001421A1 (es) Uso de dronedarona en la preparacion de medicamentos utiles para la prevencion de fibrilacion o aleteo auricular persistentes.
NO20091386L (no) Fenyloksyanilinderivater
WO2007130902A3 (en) Therapeutic cyclopentane derivatives
CY1110787T1 (el) Νεα μορφινικα παραγωγα
MY139425A (en) Pharmaceutical composition comprising 2,4-dichlorobenzyl alcohol and amylmetacresol
WO2007089743A3 (en) Potassium channel inhibitors
NO20085267L (no) Derivater av 2-alkoksy -3,4,5-trihydroksy-alkyl amider, fremstilling og anvendelse derav, samt sammensetninger inneholdende samme
ATE526972T1 (de) Kaliumkanalhemmer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application